Oracle beats on top and bottom lines as cloud revenue jumps

Norge Nyheter Nyheter

Oracle beats on top and bottom lines as cloud revenue jumps
Norge Siste Nytt,Norge Overskrifter
  • 📰 CNBC
  • ⏱ Reading Time:
  • 16 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 72%

Oracle's cloud infrastructure revenue growth accelerated in the quarter, although revenue from cloud and on-premises licenses declined.

During the quarter, some of the company's cloud services received approval for use at U.S. defense and intelligence agencies.Larry Ellison, Oracle's chairman and technology chief, speaks at the Oracle OpenWorld conference in San Francisco on September 16, 2019.shares climbed as much as 5% in extended trading on Monday after the software vendor announced fiscal fourth-quarter results that exceeded Wall Street's expectations.$1.67 per share, adjusted, vs. $1.

The company's top source of revenue, cloud services and license support, jumped 23% to $9.37 billion. But revenue from cloud licenses and on-premises declined 15% to $2.15 billion. Revenue from cloud infrastructure totaled $1.4 billion, which was up 76%, accelerating from 55% growth in the

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

CNBC /  🏆 12. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Stocks making the biggest moves before the bell: Nasdaq, Illumina, Oracle, Carnival & moreStocks making the biggest moves before the bell: Nasdaq, Illumina, Oracle, Carnival & moreThese are the stocks posting the largest moves in premarket trading.
Les mer »

Oracle’s stock picks up an upgrade, and it’s about more than just earningsOracle’s stock picks up an upgrade, and it’s about more than just earningsOracle Corp. could emerge as yet another beneficiary of the artificial-intelligence mania, according to a new bull.
Les mer »

Biogen stock climbs on drug approval recommendation, Oracle shares rise ahead of earnings, and other stocks on the moveBiogen stock climbs on drug approval recommendation, Oracle shares rise ahead of earnings, and other stocks on the moveHere are some of the biggest movers of Monday.
Les mer »

Wall St gains as focus turns to inflation data, Fed rate verdictWall St gains as focus turns to inflation data, Fed rate verdictWall Street's main indexes rose on Monday as investors awaited inflation data and the Federal Reserve's interest rate decision this week, while Oracle Corp hit a record high ahead of its quarterly results later in the day.
Les mer »

U.S. stocks extend rally; investors bet Fed will pause rate hikesU.S. stocks extend rally; investors bet Fed will pause rate hikesU.S. stocks rallied on Monday, putting the S&P 500 within striking distance of its highest close since April 2022, and Oracle hit a record high ahead of quarterly results as investors awaited inflation data and the Federal Reserve's interest rate decision this week.
Les mer »



Render Time: 2025-03-06 06:19:04